JP2024532768A - カンプトテシン誘導体、その薬物組成物およびその応用 - Google Patents
カンプトテシン誘導体、その薬物組成物およびその応用 Download PDFInfo
- Publication number
- JP2024532768A JP2024532768A JP2024508407A JP2024508407A JP2024532768A JP 2024532768 A JP2024532768 A JP 2024532768A JP 2024508407 A JP2024508407 A JP 2024508407A JP 2024508407 A JP2024508407 A JP 2024508407A JP 2024532768 A JP2024532768 A JP 2024532768A
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- reaction solution
- added
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110955364 | 2021-08-19 | ||
| CN202110955364.5 | 2021-08-19 | ||
| CN202111515247.3 | 2021-12-13 | ||
| CN202111515247 | 2021-12-13 | ||
| CN202210515797 | 2022-05-12 | ||
| CN202210515797.3 | 2022-05-12 | ||
| PCT/CN2022/113499 WO2023020605A1 (zh) | 2021-08-19 | 2022-08-19 | 喜树碱衍生物、其药物组合物及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532768A true JP2024532768A (ja) | 2024-09-10 |
| JP2024532768A5 JP2024532768A5 (cg-RX-API-DMAC7.html) | 2025-08-27 |
Family
ID=85239565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508407A Pending JP2024532768A (ja) | 2021-08-19 | 2022-08-19 | カンプトテシン誘導体、その薬物組成物およびその応用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250270227A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4389752A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024532768A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240049583A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117769555A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022330892A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3228345A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023020605A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024510435A (ja) | 2021-03-18 | 2024-03-07 | シージェン インコーポレイテッド | 生体活性化合物の内部移行複合体からの選択的薬物放出 |
| KR20250004952A (ko) * | 2022-03-17 | 2025-01-08 | 씨젠 인크. | 캄프토테신 접합체 |
| JP2025515988A (ja) * | 2022-05-13 | 2025-05-23 | シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド | カンプトテシン化合物、その調製方法及びその使用 |
| IL322897A (en) * | 2023-02-23 | 2025-10-01 | Phrontline Biopharma Hangzhou Co Ltd | Camptothecin derivatives and conjugates, methods for their preparation and medical uses |
| WO2024210687A1 (ko) * | 2023-04-06 | 2024-10-10 | 주식회사 피노바이오 | 항암 내성 극복을 위한 신규 캄토테신 유도체 및 이를 포함하는 항체-약물 접합체 |
| CN120858098A (zh) * | 2023-05-04 | 2025-10-28 | 四川科伦博泰生物医药股份有限公司 | 稠环化合物及其制备方法和应用 |
| CN120826405A (zh) * | 2023-05-04 | 2025-10-21 | 四川科伦博泰生物医药股份有限公司 | 具有靶向作用的偶联物及其制备方法和用途 |
| WO2025153001A1 (zh) * | 2024-01-17 | 2025-07-24 | 北京泰德制药股份有限公司 | 含有噻唑[5,4-b]吡啶结构的抗体偶联药物及其用途 |
| WO2026130566A1 (zh) * | 2024-12-20 | 2026-06-25 | 上海复宏汉霖生物技术股份有限公司 | 一种配体-药物偶联物及其制备方法和应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05222048A (ja) * | 1991-10-29 | 1993-08-31 | Glaxo Inc | 水溶性カンプトテシン誘導体 |
| WO2019236954A1 (en) * | 2018-06-07 | 2019-12-12 | Seattle Genetics, Inc. | Camptothecin conjugates |
| WO2020219287A1 (en) * | 2019-04-26 | 2020-10-29 | Immunogen, Inc. | Camptothecin derivatives |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1036197C (zh) * | 1992-01-28 | 1997-10-22 | 格拉克索有限公司 | 水溶性喜树碱衍生物 |
| JPH1171280A (ja) * | 1997-06-26 | 1999-03-16 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| CN111936169A (zh) * | 2018-04-06 | 2020-11-13 | 西雅图遗传学公司 | 喜树碱肽缀合物 |
| AU2022216696A1 (en) * | 2021-02-05 | 2023-08-17 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Camptothecin compound, preparation method therefor, and application thereof |
| CN120093941A (zh) * | 2021-02-09 | 2025-06-06 | 苏州宜联生物医药有限公司 | 生物活性物偶联物及其制备方法和用途 |
| KR20240031235A (ko) * | 2021-05-27 | 2024-03-07 | 자임워크스 비씨 인코포레이티드 | 캄프토테신 유사체, 접합체 및 사용 방법 |
| CN117940432B (zh) * | 2021-09-01 | 2025-12-23 | 上海弼领生物技术有限公司 | 一种喜树碱类化合物、其制备方法和用途 |
| KR20250004952A (ko) * | 2022-03-17 | 2025-01-08 | 씨젠 인크. | 캄프토테신 접합체 |
| WO2023217227A1 (zh) * | 2022-05-12 | 2023-11-16 | 先声再明医药有限公司 | 喜树碱类衍生物及配体-药物偶联物 |
| JP2025515988A (ja) * | 2022-05-13 | 2025-05-23 | シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド | カンプトテシン化合物、その調製方法及びその使用 |
-
2022
- 2022-08-19 JP JP2024508407A patent/JP2024532768A/ja active Pending
- 2022-08-19 EP EP22857914.0A patent/EP4389752A4/en active Pending
- 2022-08-19 CA CA3228345A patent/CA3228345A1/en active Pending
- 2022-08-19 KR KR1020247009078A patent/KR20240049583A/ko active Pending
- 2022-08-19 AU AU2022330892A patent/AU2022330892A1/en active Pending
- 2022-08-19 US US18/684,477 patent/US20250270227A1/en active Pending
- 2022-08-19 WO PCT/CN2022/113499 patent/WO2023020605A1/zh not_active Ceased
- 2022-08-19 CN CN202280054490.6A patent/CN117769555A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05222048A (ja) * | 1991-10-29 | 1993-08-31 | Glaxo Inc | 水溶性カンプトテシン誘導体 |
| WO2019236954A1 (en) * | 2018-06-07 | 2019-12-12 | Seattle Genetics, Inc. | Camptothecin conjugates |
| WO2020219287A1 (en) * | 2019-04-26 | 2020-10-29 | Immunogen, Inc. | Camptothecin derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117769555A (zh) | 2024-03-26 |
| EP4389752A1 (en) | 2024-06-26 |
| AU2022330892A1 (en) | 2024-03-21 |
| WO2023020605A1 (zh) | 2023-02-23 |
| KR20240049583A (ko) | 2024-04-16 |
| EP4389752A4 (en) | 2025-08-20 |
| CA3228345A1 (en) | 2023-02-23 |
| US20250270227A1 (en) | 2025-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20240049583A (ko) | 캄프토테신 유도체, 이의 약학 조성물 및 이의 응용 | |
| CN112745335B (zh) | 一种三并杂环化合物及其用途 | |
| CN115192577A (zh) | Kras突变蛋白抑制剂 | |
| CN112300153B (zh) | 一种杂环化合物、药物组合物和用途 | |
| JP2025515988A (ja) | カンプトテシン化合物、その調製方法及びその使用 | |
| CN112851663B (zh) | 一种并杂环化合物及其用途 | |
| CA3161739A1 (en) | Triazolopyridazine derivative, preparation method therefor, pharmaceutical composition thereof, and use thereof | |
| JP2020530490A (ja) | アンドロゲン受容体拮抗薬として使用されるジアリールチオヒダントイン化合物 | |
| CN114591352B (zh) | 一种三唑并哒嗪类化合物及其应用 | |
| CN113286796A (zh) | 喜树碱衍生物及其水溶性前药、包含其的药物组合物及其制备方法和用途 | |
| TW202421129A (zh) | 用作 cdk4 激酶抑制劑的化合物及其應用 | |
| JP2022547815A (ja) | アザヘテロアリール化合物及びその使用 | |
| CN111630047B (zh) | 含有羧酸基团的苯并氮杂环类化合物及其制备方法和用途 | |
| JP2025536384A (ja) | ピペリジノピリミジン系誘導体、その調製方法及びその医薬的使用 | |
| CN113929681A (zh) | 四环类衍生物及其制备方法和用途 | |
| JP2025539116A (ja) | Cdk2阻害剤及びその調製方法と使用 | |
| CN111848629B (zh) | 一类mTOR/HDAC双重抑制剂及其应用 | |
| EP4293029A1 (en) | Azaheteroaryl compound, preparation method therefor, and application thereof | |
| JP4940152B2 (ja) | パモ酸オランザピン二水和物 | |
| CN117177979B (zh) | 环状双苄基四氢异喹啉类化合物及其制备方法和应用 | |
| EP4647429A1 (en) | Pyridazinone heterocyclic compound myosin ii inhibitor and use thereof | |
| EP4371977A1 (en) | Arylamino derivative estrogen receptor modulator and use thereof | |
| HK40107233A (en) | Camptothecin derivative, and pharmaceutical composition and use thereof | |
| JP2025518997A (ja) | Tyk2阻害薬としてのピリダジン-3-カルボキサミド化合物 | |
| JP2025506747A (ja) | イミダゾピリダジン系誘導体、その製造方法、医薬組成物及び使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250818 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250818 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20260421 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260512 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260807 |